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Abstract
Age at menarche (AM) and age at natural menopause (ANM) define the boundaries of the reproductive lifespan in women.
Their timing is associated with various diseases, including cancer and cardiovascular disease. Genome-wide association
studies have identified several genetic variants associated with either AM or ANM in populations of largely European or
Asian descent women. The extent to which these associations generalize to diverse populations remains unknown.
Therefore, we sought to replicate previously reported AM and ANM findings and to identify novel AM and ANM variants
using the Metabochip (n = 161,098 SNPs) in 4,159 and 1,860 African American women, respectively, in the Women’s Health
Initiative (WHI) and Atherosclerosis Risk in Communities (ARIC) studies, as part of the Population Architecture using
Genomics and Epidemiology (PAGE) Study. We replicated or generalized one previously identified variant for AM,
rs1361108/CENPW, and two variants for ANM, rs897798/BRSK1 and rs769450/APOE, to our African American cohort. Overall,
generalization of the majority of previously-identified variants for AM and ANM, including LIN28B and MCM8, was not
observed in this African American sample. We identified three novel loci associated with ANM that reached significance after
multiple testing correction (LDLR rs189596789, p = 5610208; KCNQ1 rs79972789, p = 1.9610207; COL4A3BP rs181686584,
p = 2.9610207). Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers
(rs11604207, p = 1.6610206). While most associations were identified in either AM or ANM, we did identify genes
suggestively associated with both: PHACTR1 and ARHGAP42. The lack of generalization coupled with the potentially novel
associations identified here emphasize the need for additional genetic discovery efforts for AM and ANM in diverse
populations.
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Introduction
Age at menarche (AM) and age at natural menopause (ANM)
are components of the reproductive lifespan in women. Timing
of these reproductive milestones is associated with various
diseases and cancers such as type 2 diabetes, cardiovascular
disease, endometrial and breast cancers, as well as with fertility
issues [1–9].
Both cross-sectional and longitudinal studies have shown an
overall decline in age of menarche in US girls from the 1960s to
the 1990s [10–16]. These studies have also shown clear differences
in age of sexual maturation of European Americans compared to
African Americans, with African American girls attaining menar-
che earlier than European American girls [13]. Childhood obesity,
higher in African American adolescents than other groups, has
been linked to the earlier timing of menarche observed compared
with European Americans [13,17–19]. A genetic component for
the timing of menarche has been investigated in numerous twin
and large population studies, with heritability estimates ranging
from 0.49 in the Fels Longitudinal Study to 0.72 in the
Breakthrough Generations Study [11,20–22].
Similar to the timing of age at menarche, the age at which
natural menopause occurs is affected by multiple factors [23].
Active smoking is consistently associated with earlier menopause;
however, the effects of exposure to other carcinogens and
endocrine disruptors have not been completely elucidated [24–
26]. Diet and obesity are also suggested to impact the timing of
natural menopause [27,28]. Based on twin studies and mother-
daughter pairs, the heritability of age at natural menopause has
been estimated to be between 44–63% [29–31]. Family history of
the timing of these reproductive events is a strong predictor of both
AM and ANM [29–31].
Genetic and environmental factors that determine AM and
ANM have been considered in numerous studies, but many of
these studies have conflicting or unreplicated results [32–34].
Furthermore, the majority of these studies have been performed in
cohorts of largely European or Asian descent [35–39]. As a result,
generalization of genetic associations with AM/ANM to other
race/ethnicities is lacking. A recent review has noted the absence
of studies with non-European-descent ethnicities and suggests
expanding future studies to include other race/ethnicities [40] to
identify genetic factors that influence AM/ANM across all
populations. Replication of known ANM loci identified in
European-descent women has been demonstrated in Hispanic
women in the Women’s Health Initiative (WHI); however, to our
knowledge, there has been no genome-wide association study
(GWAS) or generalization study published to date on AM or ANM
with an African American cohort [41].
In this study, we used data from the Metabochip genotyping
array to characterize previously identified variants associated with
menarche and menopause in African Americans in a combined
cohort of African-American women from the Women’s Health
Initiative (WHI) and Atherosclerosis Risk in Communities (ARIC)
studies [42] as part of the Population Architecture using Genomics
and Epidemiology (PAGE) Study [43]. The Metabochip array is
based on the Illumina iSelect platform and contains approximately
200,000 single nucleotide polymorphisms (SNPs) consisting of
GWAS index variants and fine-mapping common and less
common variants for GWAS-identified regions relevant to
metabolic and cardiovascular traits [43,44]. Using current GWAS
and candidate gene literature as a guide, we attempted to
generalize previously identified menarche and menopause SNPs
and gene regions identified in European-descent populations to
African Americans in the PAGE Study. We then sought to identify
novel SNPs associated with AM and/or ANM.
Materials and Methods
Study Participants
Women participants from two cohorts of the PAGE Study [42],
Atherosclerosis Risk in Communities Study (ARIC) and the
Women’s Health Initiative (WHI), were included in these analyses.
ARIC is a population-based prospective study of cardiovascular
diseases and their causes in ,16,000 men and women aged 45–64
at baseline [45]. Participants were recruited in Forsyth County,
N.C., Jackson, M.S., Minneapolis, M.N., and Washington
County, M.D. From this group, 2,070 women, all of self-reported
African American ancestry and with information on reproductive
timing, were selected for study. The WHI is a long term national
health study investigating the leading causes of mortality and
frailty in post-menopausal women in the United States, including
heart disease, breast and colorectal cancer, and osteoporotic
fractures [46]. A subset of 2,455 self-reported African American
women selected based on consent to use DNA and availability of
DNA, blood lipids, and glucose and insulin measurements were
included in this study. The appropriate institutional review board
at each participating study site approved all procedures, and
written informed consent was obtained from all participants.
Definition of Age at Menarche and Age at Natural
Menopause
Age at menarche was defined as the age when menstrual periods
started in years, with extreme values pooled in groups of 9 years or
less and 17 years or older. Age at natural menopause was defined
as the age at which cessation of regular menstrual periods due to
the body’s natural aging process occurred. In ARIC, women were
asked, ‘‘Was your menopause natural or the result of surgery or
radiation?’’ Only women who indicated natural menopause were
included. Women in WHI who underwent hysterectomy, oopho-
rectomy, or hormone replacement therapy before the onset of
natural menopause were excluded. In both studies, women
reporting age at natural menopause ,40 years were excluded;
women reporting age at natural menopause .60 years were
censored at age 60. All women included in the present study were
post-menopausal.
Genotyping
Genotyping was performed on the Metabochip, a custom
Illumina iSelect genotyping chip designed to genotype SNPs
associated with metabolic traits and cardiovascular disease [43,44].
The array also includes 2,207 SNPs associated at genome-wide
significance to any trait published in the NHGRI GWAS catalog
as of August 1, 2009. For each of these GWAS-identified SNPs, an
additional proxy SNP with r2.0.90 in the CEU HapMap II
dataset, plus up to four additional SNPs with r2.0.5 in the YRI
HapMapII dataset were also included on the array. Lastly, SNPs
selected to fine-map regions of interest related to metabolic traits,
copy number variant-tagging SNPs, Major Histocompatibility
Complex (MHC) SNPs, SNPs on the X and Y chromosomes,
mitochondrial DNA SNPs, and ‘‘wildcard’’ SNPs were also
targeted, for a total of approximately 200,000 SNPs. Of these,
161,098 (81.9%) passed quality control filters for tests of Hardy-
Weinberg Equilibrium (.161027) and genotyping efficiency
(.95% call rate). There was no filter for minor allele frequency.
The design and performance of this genotyping chip in this
African American sample has been described in detail elsewhere
[43].
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Statistical Analysis
All participants self-reported African American ancestry. To
adjust for potential population stratification, we used the principal
components method implemented in Eigenstrat [47]. We excluded
any ancestry outliers further than eight standard deviations away
from the mean for the first ten principal components determined
by EIGENSOFT.
Linear regression was performed assuming an additive genetic
model to test for associations between individual SNPs and the
outcomes of age at menarche in years. We examined two
models for menarche: 1) a minimally adjusted model that
accounted only for study sites and principal components, and 2)
a fully adjusted model that included study site, year of birth,
principal components, and body mass index at ascertainment,
with the understanding that BMI at ascertainment may be a
poor proxy for BMI at age of menarche. Age at menarche was
self-reported many years later at time of examination, which has
been shown to be fairly accurate [48]. We studied one model
for natural menopause using Cox’s proportional hazards for
time-to-event (natural menopause) analysis, which adjusted for
study site, principal components, and year of birth. Women
with a missing age at menopause, an age at menopause ,40
years, or hysterectomy, oophorectomy, or hormone replacement
therapy after age 40 but prior to menopause, were excluded
from the study. Women who had menopause .60 years had
their ANM set as censored at age 60. A fixed effects meta-
analysis was then performed using METAL to obtain effect size
and standard error (SE) estimates [49]. All analyses were carried
out in either METAL or the R software package, and data
were plotted using LocusZoom [50,51]. Statistical power to
detect an expected association was estimated in Quanto [52]
assuming the observed sample size and coded allele frequency
in this African American cohort and the genetic effect size
previously reported in the literature.
The overall goal of the study was to test for SNPs associated
with AM and/or ANM using the Metabochip in African
Americans from the WHI and ARIC studies. We looked to
generalize to our population of African American women genes,
gene regions (400 kb upstream and downstream of a gene of
interest), and SNPs described in previous GWAS and candidate
gene studies associated with AM and ANM. We tested all SNPs
in the regions regardless of linkage disequilibrium (LD) with the
index SNP, although we only considered a test of association
generalized if the tested SNPs were identical to the index SNP
or in strong LD with the index variant in HapMap CEU
samples. For each candidate gene, we plotted results of single
SNP tests of association using LocusZoom and examined
regions 400 kb upstream and downstream of the gene/gene
region of interest. Tests of association were considered
significant for generalization at a liberal threshold of p,0.05.
For previously reported variants not genotyped in our study, we
identified SNPs in LD with our directly genotyped SNPs [53]
and reported results from our minimally adjusted model (Model
1) for the proxy SNPs.
In addition to generalization, we sought to discover novel SNP-
trait associations using the entire Metabochip. Significance in this
discovery phase was defined as p,3.1610207, after Bonferroni
correction (0.05/161,098). Because this threshold is highly
conservative given the correlation among the SNPs on the
Metabochip, we also defined an arbitrary suggestive significance
level as p,161024 in the discovery phase.
Results
Study Population
A total of 4,159 and 1,860 African American female partic-
ipants met the study definitions for AM and ANM, respectively,
and both PAGE studies were represented roughly equally
(Table 1). In ARIC, the mean age at menarche was 12.9 years,
which was slightly greater than the mean age at menarche in WHI
(12.6 years) (Table 1). For ANM, the WHI group had a slightly
later average onset than ARIC (Table 1).
Age at Menarche: Generalization to PAGE African
Americans
To generalize previously-associated genetic variants in our
African American population, we examined regions/genes previ-
ously associated with AM from either published candidate gene
studies or GWAS: CYP19A1, CYP17, CYP1B1, FTO, LIN28B,
9q31.2 region, IGF1, TNFSF11, TNFRSF11A, and LHCGR [35–
37,54–59]. We also evaluated forty-two SNPs associated with AM
identified in a recent meta-analysis by Elks et al. of .87,000
European-descent women from forty-nine studies [35].
Overall, 11/21 (52%) SNPs previously identified for AM from
earlier studies and 15/42 (36%) from the Elks et al. meta-analysis
were directly genotyped or in strong (r2.0.70) LD in the CEU
panel of HapMap with those genotyped (Table 2 and Table S1,
respectively), and one generalized to this African American cohort:
rs9385399, in LD with previously reported rs1361108 (r2 = 1.00,
p = 0.01) (Table S1). Representative results of tests of association
and LD in this African American sample are given for CYP19A1,
FTO, LIN28B, and CYP1B1– genes previously associated with AM
(Figure 1) [35,36,54,60]. Three SNPs in LIN28B were included on
the Metabochip (rs314277, rs4946651, and rs7759938), and while
the direction of genetic effect was consistent with previous reports,
all failed to reach statistical significance in this sample (p.0.30).
Four additional SNPs in LD with these LIN28B SNPs were also
not significant. At the 9q31 locus, rs7861820 and rs4452860, both
located downstream of TMEM38B, had betas opposite to prior
reports [36,37]. Neither SNP nor their proxy SNPs were
significant at p,0.05. Similarly, SNPs in LD (rs1856142 and
rs605765) with previously associated variants in and around FSHB
were not significantly associated with AM in this African American
sample, though rs605765 (b=20.06) had the same direction of
effect and comparable magnitude as rs1782507 (b=20.07) [59].
Results obtained under our fully adjusted model (Model 2) were
similar to those of Model 1 and are available in Table 2.
We also examined SNPs associated with AM that were reported
in a recent meta-analysis performed by Elks et al. for the
ReproGen Consortium [35]. Of the forty-two SNPs associated
with AM in Elks et al., we detected an association with rs9385399
(p = 0.01), located downstream of CENPW, which is a perfect
proxy (r2 = 1.00) for previously associated variant rs1361108, and
the only SNP to generalize to our African American sample. We
also identified an association with rs2947411 (p = 0.02) with AM
(Table S1), though the directions of effect were opposite. One
additional SNP, rs4929923 (p= 0.06), nearly reached the signif-
icance threshold and had a similar magnitude and direction of
effect compared with the previous report. Overall, AM SNPs from
previously published studies of European-descent women, includ-
ing the Elks et al. meta-analysis, did not generalize to our PAGE
African American population.
Genetics of Age at Menarche and Natural Menopause
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Age at Natural Menopause: Generalization to PAGE
African Americans
As with AM, to generalize results to our African American
population, we examined previously identified 400 kb regions
around genes associated with ANM from published candidate
gene studies and GWAS: APOE, CYP1B1, CYP19A1, CYP17A1,
ESR2, BRSK1, FSHB, IGF2R, PPARG, TNFSF11, TNFRSF11A,
BMP15, AMHR2, TMEM224, MCM8, and IGF1 (Figure 2,
Table 3) [36,38,58,59,61–65]. We also examined twenty SNPs
associated with ANM that were identified in a recent study by
Stolk et al. [66] (Table S2).
Overall, 14/23 (40%) SNPs previously identified for ANM via
GWAS and 6/20 SNPs from the Stolk et al. meta-analysis were
directly genotyped on the Metabochip or were in strong LD
(r2.0.70) in CEU panel of HapMap. 1/12 (8%) of the tested SNPs
in these regions/genes generalized to this African American
sample: rs8113016 (Table 3). Rs8113016, located in an intron of
TMEM150B/TMEM224 and downstream of BRSK1, is in LD
with previously reported rs897798 (r2 = 0.72) and was associated
with ANM in our sample (p = 0.03). An intronic APOE variant,
rs769450, was associated with ANM (p=0.03), though the
nonsynonymous APOE rs7412 was not (p = 0.55); these SNPs are
not in LD with each other (r2 = 0.04). In BRSK1, no previously
reported SNPs were genotyped in our study; however, directly
genotyped intronic TMEM150B rs4806660 was in very strong LD
with intronic BRSK1 rs1172822 (r2 = 0.98). BRSK1 rs1168309, in
strong LD with rs2384687 (r2 = 0.85) was not associated with
ANM in this African American sample (p = 0.59).
Three of the twenty SNPs recently identified by Stolk et al. as
associated with ANM were directly genotyped on the Metabochip.
Two of the three genotyped SNPs (rs2303369 and rs2153157) had
the same directions of effect, though the magnitudes were smaller.
Of the remaining 17 SNPs not directly targeted by the
Metabochip, three were in strong LD (HapMap CEU r2 ranging
from 0.86 to 0.91) with the SNPs identified by Stolk et al:
rs1176133, rs4668368, and rs12593363. For seven SNPs, no proxy
SNP could be identified on the Metabochip (Table S2). Of the
twenty SNPs identified in the Stolk et al. meta-analysis and directly
or indirectly represented on the Metabochip, none were associated
with ANM in this African American sample (Table S2).
Age at Menarche: Discovery
We tested all SNPs genotyped on the Metabochip for an
association with AM adjusted for study site and principal
components (Model 1) and adjusted for study site, year of birth,
principal components, and body mass index (Model 2) (Table 4).
After accounting for multiple testing (p,3.1610207), no SNPs
were significantly associated with AM in either model (Table S3).
The most significant SNP in both models was rs11604207 (Model
1: p = 1.59610206; Model 2: p = 1.82610206), which is located
upstream of RSF1, a gene encoding a chromatin remodeling
protein implicated in ovarian and breast cancers [67–69] (Table
S3).
Age at Natural Menopause: Discovery
We tested all SNPs on the Metabochip for associations with
ANM adjusted for study site and principal components. Three
SNPs were significant after Bonferroni correction (p,3.1610207):
LDLR (rs189596789, p = 4.98610208), KCNQ1 (rs79972789,
p = 1.90610207), and COL4A3BP (rs181686584,
p = 2.85610207). The most significant association was with
rs189596789, located approximately 10 kb upstream of the low-
density lipoprotein receptor (LDLR) gene, which has been
associated with familial hypercholesterolemia [70,71]. Several of
the most significant SNPs for ANM were located in/near genes
previously associated with obesity, type 2 diabetes (T2D), coronary
artery disease and lipid metabolism, e.g., LDLR (rs189596789),
NOS1AP (rs76078015), DGKB (rs74486449), LYPLAL1
(rs78696400), and CDKAL1 (rs114158228) (Table 4). We were
unable to generalize the previously reported association between
ANM and PPARG rs4135280 in this African American sample.
Two genes were suggestively associated with both ANM and
AM at a nominal significance threshold. PHACTR1 was sugges-
tively associated with AM (rs73725617; Table S3) and ANM
(rs117124693; Table 4). Though the direction of effects was similar
for each SNP in PHACTR1, the SNPs are not in LD with each
other. Likewise, SNPs in ARHGAP42, located at the 11q22.1 locus,
were suggestively associated with AM (rs11224447; Table S3) and
ANM (rs11224401; Table 4), but are not in LD with each other,
though the direction of effects was the same.
Table 1. Study population characteristics of African American women from the PAGE Study.
Age at Menarche (AM) Age at Natural Menopause (ANM)
Study Population Study Population
ARIC WHI ARIC WHI
Participants (n) 2078 2081 994 866
Age at menarche, yrs/Age at
menopause, yrs
12.89 (1.76) 12.56 (1.64) 47.97 (3.83) 50.84 (4.50)
Age at enrollment, yrs 53.36 (5.73) 61.01 (6.87) 53.07 (5.75) 61.30 (6.78)
Body mass index, kg/m2 30.86 (6.63) 31.34 (6.83) 31.29 (6.94) 30.95 (6.76)
Weight, lbs. 181.05 (39.68) 182.87 (41.26) 183.78 (40.80) 181.05 (40.63)
Height, in. 64.24 (2.43) 64.00 (2.63) 64.31 (2.38) 64.05 (2.75)
Decade of birth, #(%) 1910s – 26 (1.24) – 12 (1.39)
1920s 504 (24.07) 414 (19.82) 221 (22.23) 183 (21.13)
1930s 1083 (51.72) 981 (46.96) 522 (52.52) 414 (47.81)
1940s 507 (24.21) 668 (31.98) 251 (25.25) 257 (29.68)
Data presented as means (sd) unless otherwise noted. Abbreviations: Atherosclerosis Risk in Communities (ARIC) and Women’s Health Initiative (WHI).
doi:10.1371/journal.pone.0055258.t001
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Discussion
Here we demonstrated the use of the Metabochip genotyping
array to identify SNPs associated with AM and ANM in a sample
of African American women. Previous GWAS studies for AM and
ANM have been performed in primarily European descent
populations; generalization to diverse populations has largely been
lacking [72]. Our study is the first, to our knowledge, to consider
this trait in a large African American cohort. We were able to
generalize only one previously identified variant for AM and two
variants for ANM to our African American cohort [AM:
rs1361108; ANM: rs897798 and rs9385399 (proxy for
rs1361108)]. Overall, however, we were unable to generalize the
majority of significant associations for previously identified SNPs
associated with AM, including LIN28B or the 9q31 locus, or with
ANM, including MCM8 or TMEM150b/TMEM224, which have
recently been identified in several GWAS of European-descent
women. Our inability to replicate earlier findings in our African
American sample may have, in part, resulted from scant
Metabochip coverage of these regions. The emphasis of the
Metabochip on genes involved in lipid metabolism and cardio-
vascular traits is evident comparing coverage in the FTO region
(1053 SNPs) to the LIN28B region (28 SNPs).
In the discovery phase of our AM analysis, none of our results
reached genome-wide significance. However, the ANM analysis
Figure 1. Regional Association Plots for Age at Menarche in African American women in the PAGE Study. Locus Zoom plots for selected
gene regions in age at menarche analysis. Vertical axis is –log10 of the p-value, the horizontal axis is the chromosomal position. Each dot represents a
SNP tested for association with age at natural menopause in 1,860 African American women from the PAGE Study. Approximate linkage
disequilibrium between the most significant SNP, listed at the top of each plot, and the other SNPs in the plot is shown by the r2 legend in each plot.
(A) Locus Zoom plot for the CYP19A1 region, with rs10519297 the most significant SNP in the region. (B) Locus Zoom plot for the FTO region;
rs2689243 was the most significant SNP in the plot region. (C) LIN28B region Locus Zoom plot; rs408949 was the most significant SNP in the plot
region. (D) Locus Zoom plot of the CYP1B1 region; rs13391045 was the most significant SNP in the plot region.
doi:10.1371/journal.pone.0055258.g001
Genetics of Age at Menarche and Natural Menopause
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yielded three associations that were significant after multiple
testing corrections. Broadly, we demonstrate the ability to
potentially uncover new variants associated with age at natural
menopause in our African American cohort using the Metabochip.
Several studies have shown relationships between a woman’s
reproductive milestones (AM, ANM, parity) and menstrual
characteristics and risk for breast cancer, endometrial cancer,
and ovarian cancer [73–77] and chronic diseases such as diabetes,
osteoporosis and cardiovascular disease (briefly [78–80] ). The
most significant result in the ANM analysis was a SNP located
upstream of LDLR (rs189596789) which encodes a low density
lipoprotein receptor implicated in familial cholesterolemia. KCNQ1
(rs79972789) also reached genome wide significance in our ANM
analysis. Numerous variants in KCNQ1 have also been implicated
in type 2 diabetes in several populations, though none were in
linkage disequilibrium with rs79972789 [81–86]. Recently, Buber
et al. evaluated the role of menopausal hormonal changes with
cardiac events in women with mutations in KCNQ1 and congenital
long-QT syndrome (LQTS) [87] and determined the onset of
menopause was associated with an increase in the risk of cardiac
events in LQTS women. Though not significant, suggestive AM
associations included LPL and CYP4F22, which are associated with
Figure 2. Regional Association Plots for Age at Natural Menopause in African American women in the PAGE Study. Locus Zoom plots
for selected gene regions in age at natural menopause analysis. Vertical axis is the –log10 of the p-value, the horizontal axis is the chromosomal
position. Each dot represents a SNP tested for association with age at natural menopause in 1,860 African American women from the PAGE Study.
Linkage disequilibrium between the most significant SNP, listed at the top of each plot, and the other SNPs in the plot is shown by the r2 legend in
each plot. (A) Locus Zoom plot for the APOE region, with rs78916952 the most significant SNP in the region. (B) Locus Zoom plot for the MCM8
region; rs237688 is the most significant SNP in the plot region. (C) FSHB region Locus Zoom plot; rs605765 is the most significant SNP in the plot
region. (D) Locus Zoom plot of the BRSK1 region with rs11672111 as the most significant SNP in the plot region.
doi:10.1371/journal.pone.0055258.g002
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type 2 diabetes and lipid metabolism (rs1372339, rs4922116,
rs1273516), and TMEM18 (rs2947411), associated with obesity
and body mass index [88,89]. These ANM associations and
suggestive AM associations with genes involved in cardiovascular
function, lipid metabolism, and type 2 diabetes concur with
research showing later AM lowers obesity and diabetes risk while
earlier ANM increases risk for cardiovascular disease, obesity and
insulin resistance [90,91].
Different pathways appear to be involved in the initiation and
cessation of menses. Prior GWAS and linkage studies performed in
European descent or Asian populations for AM and ANM show
little concordance with specific genes (reviewed in [5]). Our
analysis is consistent with this observation. Only PHACTR1 and
ARHGAP42 SNPs were suggestively significant in both our AM
and ANM analyses. PHACTR1 is a phosphatase and actin
regulator which has been implicated in coronary artery disease
[92,93]. Its role in menarche and menopause is yet to be
determined. ARHGAP42, a Rho GTPase activating protein, has
not yet been evaluated for a role in menarche or menopause. A
GWAS identified intronic ARHGAP42 rs633185 is associated with
blood pressure [94], but this variant is not in strong LD with
ARHGAP42 variants suggestively associated with either AM or
ANM in this study. A recent study by Lu et al., found SNPs in both
TNFSF11 and TNFRSF11A significant for AM and ANM [58].
SNPs genotyped on the Metabochip were in weak LD with the
reported SNPs and failed to reach significance in this African
American sample. Given the role that both PHACTR1 and
ARHGAP42 play in atherosclerosis, osteoporosis and the develop-
ment of lactation glands in pregnancy, further investigation on the
influence of these genes in AM and ANM is warranted [95,96].
The Metabochip was designed to be a cost-effective method of
genotyping approximately 200,000 metabolic and cardiovascular
SNPs and SNPs in other useful regions of the genome, such as the
HLA region and the X and Y chromosomes. Overall, median SNP
density on the Metabochip is approximately one SNP per 370
bases [43]. This coverage appears sufficient to replicate some loci
associated with both cardiovascular or metabolic traits and AM/
ANM. However, we found instances of previously identified genes
for AM/ANM with little/no Metabochip coverage (CYP1B1,
LIN28B, ESR2, and BRSK1) which may have impacted our results.
Additionally, prior studies that identified SNPs associated with AM
and ANM were performed primarily in European-descent cohorts.
Though our study included over 4,000 African American women,
we had limited power to identify significant associations in most
previously identified loci, which may explain why we failed to
detect the same associations identified in European-descent
Table 3. Comparison of GWAS-identified ANM variants in African American women in PAGE Study.
Locus Gene/region
Prior GWAS in European descent
women African American women from the PAGE Study
SNP Chr
Coded
Allele Beta P-value Ref.
Best Proxy SNP
from present
study
r2 in HapMap
CEU/YRI
Coded
Allele Beta (SE)
P-
value
rs16991615 20 MCM8 A 1.07 1.21E-21 [36,62] rs16991615 – A 20.17(0.15) 0.25
rs236114 20 MCM8 A 0.50 9.71E-11 [38] rs236114 – A 0.02(0.06) 0.69
rs1172822 19 BRSK1 T 20.49 1.8E-19 [36,38] rs4806660 0.98/0.64 A 0.002(0.03) 0.97
rs2384687 19 BRSK1 C 20.47 2.4E-18 [36] rs11668309 0.85/0.43 A 0.02(0.04) 0.59
rs897798 19 BRSK1 G 20.40 1.1E-14 [36] rs8113016 0.72/0.02 A 0.12(0.05) 0.03
rs1065778 15 CYP19A A – 0.05 [61] rs10519297 0.90/0.32 A 20.01(0.05) 0.84
rs2255192 15 CYP19A A – 0.04 [61] rs10459592 0.32/0.02 A 20.02(0.04) 0.52
rs621686 11 FSHB A 0.32 0.007 [59] rs1856142 0.27/0.32 A 0.04(0.03) 0.29
rs7951733 11 FSHB A 20.32 0.02 [59] rs7951733 – A 0.11(0.13) 0.37
rs769450 19 APOE A – 0.007 [97] rs769450 – A 20.07(0.03) 0.03
rs7412 19 APOE – – 0.001 [98] rs7412 – A 20.03(0.05) 0.55
rs1019731 12 IGF1 C 20.28 0.005 [59] rs1019731 – A 20.03(0.11) 0.82
rs9457827 17 IGF2R T 0.37 0.04 [59] rs9457827 – A 0.04(0.04) 0.28
rs4135280 3 PPARG T 0.54 0.005 [59] rs4135280 – A 20.14(0.18) 0.42
rs1256044 14 ESR2 G – 0.03 [61] rs1268656 0.08/0.004 A 20.01(0.06) 0.88
rs1256059 14 ESR2 A – 0.05 [61] rs1268656 0.08/0.004 A 20.01(0.06) 0.88
rs1056836 2 CYP1B1 G – 0.04 [64] rs10495874 0.04/0.03 A 20.03(0.05) 0.60
rs346578 13 TNFSF11 A – 0.007 [58] rs6561072 0.07/0.07 A 0.04(0.04) 0.22
rs9525641 13 TNFSF11 T – 0.01 [58] rs931273 0.05/0.03 A 20.02(0.08) 0.81
rs8086340 18 TNFRSF11A G – 0.02 [58] rs8094440 0.10/0.01 A 0.03(0.03) 0.38
rs2002555 12 AMHR2 G 0.30 0.02 [65] rs7131938 0.59/0.54 A 0.01(0.04) 0.84
rs2384687 19 TMEM224 C 0.38 1.39E-10 [38] rs11668309 0.85/0.43 A 0.02(0.04) 0.59
rs897798 19 TMEM224 G 0.31 3.91E-08 [38] rs8113016 0.72/0.02 A 0.12(0.05) 0.03
Comparison of previously reported SNPs associated with ANM in European and Chinese descent women to 1,860 African American women from the PAGE Study. Data
presented are for the previously identified SNP. If the previously identified SNP was not directly genotyped in present study, data are shown for the best proxy SNP
based on linkage disequilibrium calculated from the International HapMap Project CEU data.
doi:10.1371/journal.pone.0055258.t003
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Table 4. ANM Discovery–SNPs associated with age at natural menopause (ANM) in African American women from the PAGE
Study.
CHR SNP GENE GENE REGION CODED ALLELE
CAF BETA SE P VALUE
19 rs189596789 LDLR upstream A 0.006 1.09 0.20 4.98E-08
11 rs79972789 KCNQ1 intronic C 0.997 21.76 0.34 1.90E-07
5 rs181686584 COL4A3BP intronic A 0.002 2.35 0.46 2.85E-07
6 rs114158228 CDKAL1 intronic A 9E-04 3.60 0.73 7.12E-07
21 rs117876865 KCNE1 downstream A 9E-04 3.58 0.73 8.55E-07
10 rs11195485 ADRA2A downstream A 0.002 2.89 0.59 9.63E-07
11 rs11224401 ARHGAP42 intronic A 0.997 2.20 0.45 1.13E-06
1 rs78937547 SEC16B downstream A 0.992 21.97 0.41 1.89E-06
17 rs75394140 KCNJ2 downstream A 0.002 20.93 0.21 6.48E-06
11 rs76988592 KCNJ1 downstream A 0.702 20.93 0.21 7.24E-06
3 rs114451007 PPARG intronic A 0.253 1.70 0.38 9.30E-06
12 rs10846771 DHX37 downstream A 0.997 20.16 0.04 9.43E-06
11 rs12804247 CCDC81 upstream A 0.655 0.17 0.04 1.45E-05
1 rs76571116 SEC16B downstream A 3E-04 21.54 0.36 1.57E-05
17 rs17634167 TTLL6 cds-synon. A 6E-04 20.34 0.08 1.62E-05
7 rs117382431 FKBP6 downstream A 0.999 4.38 1.03 2.17E-05
6 rs76294174 LOC100130357 intronic C 3E-04 4.38 1.03 2.17E-05
6 rs74918542 SCGN intronic A 0.999 24.38 1.03 2.17E-05
1 rs76078015 NOS1AP intronic A 9E-04 4.38 1.03 2.17E-05
18 rs117454233 MC4R downstream A 0.999 24.38 1.03 2.17E-05
3 rs73025249 PPARG intronic A 9E-04 4.38 1.03 2.17E-05
3 rs182857216 ETV5 intronic A 0.999 24.38 1.03 2.17E-05
3 rs73027210 PPARG intronic A 9E-04 4.38 1.03 2.17E-05
9 rs75220302 CDKN2A downstream A 0.999 24.38 1.03 2.18E-05
9 rs74599268 CDKN2B upstream A 3E-04 4.38 1.03 2.18E-05
9 rs3731245 CDKN2A intronic A 3E-04 4.38 1.03 2.18E-05
9 rs76774391 CDKN2B upstream C 3E-04 4.38 1.03 2.18E-05
2 rs117258126 IRS1 downstream A 3E-04 4.38 1.03 2.18E-05
9 rs3808846 CDKN2B 59 flanking A 3E-04 4.38 1.03 2.18E-05
9 rs77706751 CDKN2B upstream A 6E-04 4.38 1.03 2.18E-05
9 rs3808845 CDKN2B 59 flanking A 3E-04 4.38 1.03 2.18E-05
9 rs76810097 CDKN2B upstream A 3E-04 4.38 1.03 2.18E-05
9 rs36228836 CDKN2A 59 flanking A 3E-04 4.38 1.03 2.18E-05
9 rs75039118 ADAMTS13 intronic A 0.999 24.38 1.03 2.19E-05
18 rs75914913 MC4R downstream A 3E-04 4.38 1.03 2.19E-05
11 rs190060931 BUD13 downstream A 0.999 24.38 1.03 2.21E-05
2 rs186397905 IRS1 downstream C 3E-04 4.38 1.03 2.21E-05
16 rs9934222 JPH3 cds-synon. A 0.163 20.19 0.04 2.28E-05
15 rs72751410 MAP2K5 intronic A 0.998 21.51 0.36 2.30E-05
15 rs72747452 LOC100506686 intronic A 0.002 1.51 0.36 2.30E-05
11 rs180751580 NUCB2 missense C 0.999 24.36 1.03 2.30E-05
3 rs186437034 SCN5A intronic A 0.999 22.46 0.58 2.45E-05
7 rs78912482 JAZF1 upstream A 0.012 0.64 0.15 3.04E-05
1 rs116071515 SEC16B intronic A 0.002 1.88 0.45 3.06E-05
6 rs1997770 OFCC1 downstream A 0.970 20.41 0.10 3.55E-05
7 rs118135044 DGKB upstream A 4E-04 4.22 1.02 3.73E-05
11 rs74402657 ARFGAP2 intronic C 4E-04 2.93 0.72 3.96E-05
1 rs117217277 SEC16B downstream A 0.999 22.97 0.72 3.97E-05
1 rs116881786 SEC16B downstream A 0.999 22.97 0.72 3.97E-05
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Table 4. Cont.
CHR SNP GENE GENE REGION CODED ALLELE
CAF BETA SE P VALUE
1 rs76471454 SEC16B downstream A 6E-04 2.97 0.72 3.97E-05
1 rs79775735 SEC16B downstream A 6E-04 2.97 0.72 3.97E-05
1 rs79468804 SEC16B downstream A 6E-04 2.97 0.72 3.97E-05
1 rs74703854 SEC16B downstream A 0.999 22.97 0.72 3.97E-05
1 rs116923068 SEC16B downstream C 0.999 22.97 0.72 3.97E-05
1 rs117674205 SEC16B downstream C 0.999 22.97 0.72 3.97E-05
1 rs117260315 SEC16B downstream A 6E-04 2.97 0.72 3.97E-05
1 rs76020919 SEC16B downstream A 6E-04 2.97 0.72 3.97E-05
11 rs2306034 LRP4 UTR-39 A 4E-04 2.94 0.72 3.99E-05
2 rs189110944 IRS1 downstream A 4E-04 4.17 1.02 4.72E-05
5 rs1976311 KCNN2 upstream C 0.996 21.02 0.25 4.98E-05
7 rs13245084 LOC100507421 intronic A 4E-04 4.14 1.02 5.07E-05
6 rs115178932 LRRC16A intronic A 4E-04 4.14 1.02 5.07E-05
1 rs77353590 SYF2 downstream A 0.009 0.74 0.18 5.42E-05
2 rs111826230 APOB upstream A 0.984 20.58 0.14 5.47E-05
11 rs193030163 DDB2 upstream C 0.999 24.11 1.02 5.57E-05
11 rs114702513 KCNQ1 intronic A 0.996 21.23 0.31 5.60E-05
6 rs117124693 PHACTR1 intronic A 0.999 24.11 1.02 5.62E-05
6 rs181947983 SLC17A3 upstream A 4E-04 4.11 1.02 5.62E-05
15 rs183951867 CHRNB4 upstream A 9E-04 4.11 1.02 5.62E-05
9 rs191930498 CDKN2B upstream C 4E-04 4.10 1.02 5.83E-05
17 rs192656758 CCT6B downstream A 4E-04 4.10 1.02 5.86E-05
7 rs740259 JAZF1 59 flanking A 4E-04 4.09 1.02 5.97E-05
1 rs114389068 GPR153 cds-synon. A 0.005 0.93 0.23 6.07E-05
11 rs185476610 KCNQ1 intronic A 0.999 24.08 1.02 6.24E-05
16 rs246192 NDRG4 intronic C 0.256 0.15 0.04 6.25E-05
7 rs192457106 JAZF1 intronic A 0.999 24.08 1.02 6.35E-05
7 rs73702566 WBSCR22 intronic A 0.999 24.08 1.02 6.35E-05
6 rs187190790 TAP2D upstream A 0.999 24.08 1.02 6.38E-05
7 rs74984879 DGKB upstream C 0.999 22.04 0.51 6.40E-05
11 rs184056970 ARAP1 intronic A 4E-04 4.07 1.02 6.53E-05
3 rs76909367 COLQ intronic A 4E-04 4.06 1.02 6.89E-05
10 rs11187795 PLCE1 intronic A 4E-04 4.06 1.02 6.93E-05
6 rs186129489 TFAP2D intronic A 4E-04 4.05 1.02 7.12E-05
2 rs73923981 BRE intronic A 9E-04 4.05 1.02 7.32E-05
15 rs180807356 ADAMTS7 upstream A 0.999 24.04 1.02 7.52E-05
5 rs10062135 NPR3 intronic A 0.009 0.73 0.19 7.85E-05
12 rs17568045 C12orf42 intronic A 0.993 20.86 0.22 8.11E-05
1 rs116411856 WARS2 upstream A 0.003 1.32 0.34 8.16E-05
1 rs78696400 LYPLAL1 downstream A 0.985 20.58 0.15 8.96E-05
15 rs74979292 C15orf39 upstream A 0.002 1.49 0.38 9.29E-05
11 rs144204188 TRIM66 intronic A 0.002 2.79 0.72 9.39E-05
1 rs78411379 TBX15 intronic A 0.999 22.27 0.58 9.62E-05
15 rs190893945 ADAMTSL3 intronic A 0.998 21.76 0.45 9.67E-05
9 rs12555547 CDKN2B upstream C 0.998 22.30 0.59 9.69E-05
2 rs10932320 C2orf67 intronic A 0.807 20.17 0.04 9.93E-05
Tests of association at p#1E-04 from single SNP linear regressions adjusted for study site and principal components in 1,860 African American women from the PAGE
Study are shown. For each significant test of association, the chromosome, rs number, nearest gene, location, coded allele, beta, standard error (SE), and p-value are
given. Genes listed are nearest genes to the SNP as measured from the transcription start site for upstream SNPs or the transcription stop site for downstream SNPs.
Abbreviations: CAF, coded allele frequency.
doi:10.1371/journal.pone.0055258.t004
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GWAS. For specific tests of association, our power was impacted
by sample size and by minor allele frequencies. For example, the
allele frequency for rs7861820 in this African American cohort
was 0.11 compared to a higher frequency observed in HapMap
CEU (0.57; Table S4). Interestingly, we were adequately powered
(.98%) to generalize the intronic LIN28B SNP, rs314277, with
AM in our sample, yet failed to find an association with this SNP
or with SNPs in strong LD with it.
Metabochip performance in non-European populations was
recently evaluated in a pilot study in African American PAGE
participants [43]. In this pilot study, Buyske et al. demonstrated
that the majority (89%) of SNPs targeted by the Metabochip
passed rigorous quality control with high call rates [43]. Using
lipid traits as an example, Buyske et al. demonstrated that
Metabochip data can be used to replicate known GWAS-identified
SNP-trait relationships. Furthermore, the pilot study demonstrated
that Metabochip data can be used to fine-map GWAS-identified
regions to uncover potential novel index SNPs specific to African
Americans in an established locus for that trait. Fine-mapping data
for AM/ANM was not included in the Metabochip content. While
we were able to use the Metabochip to identify potentially novel
SNP-trait relationships for AM/ANM, additional fine-mapping
efforts of other loci already implicated for these traits are needed.
Furthermore, additional studies in general are warranted for
diverse (non-European descent) populations using Metabochip or
other arrays designed for fine-mapping. Admixture in the African
American population and its associated decreased LD compared
to European Americans challenge identification of trait-associated
SNPs. Targeted fine mapping, such as use of the Metabochip, may
be more appropriate in some circumstances than GWAS to
evaluate specific SNPs and regions associated with particular traits.
Although the Metabochip was designed for genotyping of
cardiovascular and metabolic SNPs, this study demonstrates the
feasibility of utilizing such a targeted chip to identify SNP
associations with age at menarche and age at natural menopause.
We identified potentially novel associations with AM/ANM at loci
implicated in cardiovascular traits, obesity and cancer. This may
result from pleiotropic loci or may suggest that the AM/ANM
timing mechanisms influence underlying disease process. With
numerous genes implicated in both metabolic and cardiovascular
phenotypes and both AM and ANM, further studies will allow us
to consider how specific genes may influence the reproductive
lifespan in women.
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